Ledger.Open graph →
SEC Form D · filed August 14, 2025

Bryn Pharma, Inc

Offering
$4.7M
Sold
$4.7M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
LEBANON, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Anne Whitaker · Lebanon, NJDirectorMichael Kaseta · Morrisville, NCDirectorJeff Hartness · Lebanon, NJDirectorSteven Hartman · Lebanon, NJDirectorMichelle Lobel · Lebanon, NJDirectorLisa Licht · Lebanon, NJDirectorJames Borneman · Lebanon, NJExecKate Soper Diaz · Lebanon, NJDirectorJoshua Ziel · Lebanon, NJExecSteven Killmeyer · Lebanon, NJExecMarc Rapaport · Santa Monica, CADirectorSandra Loreaux · Lebanon, NJDirectorAnne Whitaker · Lebanon, NJDirectorMichael Kaseta · Morrisville, NCDirectorJeff Hartness · Lebanon, NJDirectorSteven Hartman · Beverly Hills, CADirectorJoshua Ziel · Lebanon, NJExecMichelle Lobel · Beverly Hills, CADirectorSteven Killmeyer · Lebanon, NJExecMarc Rapaport · LOS ANGELES, CADirectorLisa Licht · North Hills, CADirectorSandra Loreaux · Lebanon, NJDirectorJames Borneman · Lebanon, NJExecKate Soper Diaz · Lebanon, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗